| |
| |
|
| Insider
Information: |
Janney Daniel |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
93,395 |
|
|
Indirect Shares
|
23,243,556 |
|
|
| Direct
Value |
$89,549 |
|
|
|
Indirect Value
|
$118,053,012 |
|
|
| Total
Shares |
23,336,951 |
|
|
| Total
Value |
$118,142,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
1
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -9.8%
|
-147.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AVADEL Pharmaceuticals Plc |
AVDL |
10% Owner |
2003-08-27 |
0 |
2003-08-27 |
772,088 |
Premium* |
|
|
Dynavax Technologies Corp |
DVAX |
No longer a Director |
2006-11-14 |
2,530 |
2004-02-24 |
1,522,186 |
Premium* |
|
|
Anesiva Inc |
ANSVQ |
Director, 10% Owner |
|
0 |
2010-01-06 |
16,160 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2021-05-27 |
23,449 |
2021-05-27 |
24,565 |
Premium* |
|
|
Vive Medical Inc |
VIVE |
Director |
2018-12-31 |
60,579 |
2018-12-31 |
1,381,955 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
10% Owner |
2015-04-14 |
0 |
2015-04-14 |
4,343,550 |
Premium* |
|
|
Krystal Biotech Inc |
KRYS |
Director |
2017-09-22 |
0 |
2023-06-09 |
107,362 |
Premium* |
|
|
Allakos Inc. |
ALLK |
Director, 10% Owner |
2020-01-22 |
6,837 |
2022-09-21 |
9,050,493 |
Premium* |
|
|
Sutro Biopharma Inc |
STRO |
Director, 10% Owner |
2018-10-01 |
0 |
2018-10-01 |
1,944,901 |
Premium* |
|
|
Tyra Biosciences, Inc. |
TYRA |
10% Owner |
|
0 |
2021-09-17 |
4,080,296 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRYS |
Krystal Biotech Inc |
Director |
– • – |
2023-04-19 |
4 |
AS |
$90.32 |
$713,493 |
I/I |
(7,900) |
224,462 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
Director |
– • – |
2023-05-09 |
4 |
AS |
$90.74 |
$1,551,579 |
I/I |
(17,100) |
207,362 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
Director |
– • – |
2023-05-19 |
4 |
AS |
$95.02 |
$4,751,185 |
I/I |
(50,000) |
157,362 |
0 |
% |
|
| ALLK |
Allakos Inc. |
Director |
– • • |
2021-03-26 |
4 |
S |
$115.01 |
$1,993,293 |
I/I |
(17,308) |
56,293 |
0 |
% |
|
| ALLK |
Allakos Inc. |
Director |
– • • |
2021-03-22 |
4 |
S |
$119.46 |
$1,573,790 |
I/I |
(13,148) |
73,601 |
0 |
% |
|
| ALLK |
Allakos Inc. |
Director |
– • • |
2021-03-12 |
4 |
S |
$124.18 |
$505,537 |
I/I |
(4,071) |
93,457 |
0 |
% |
|
| ALLK |
Allakos Inc. |
Director |
– • • |
2021-03-15 |
4 |
S |
$124.56 |
$835,548 |
I/I |
(6,708) |
86,749 |
0 |
% |
|
| ALLK |
Allakos Inc. |
Director |
– • • |
2021-03-11 |
4 |
S |
$124.62 |
$748,468 |
I/I |
(6,006) |
97,528 |
0 |
% |
|
| ALLK |
Allakos Inc. |
Director |
– • • |
2021-03-09 |
4 |
S |
$125.00 |
$12,500 |
I/I |
(100) |
103,534 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
Director |
– • – |
2023-06-08 |
4 |
S |
$127.86 |
$3,979,854 |
I/I |
(31,065) |
126,297 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
Director |
– • – |
2023-06-09 |
4 |
S |
$128.53 |
$2,438,223 |
I/I |
(18,935) |
107,362 |
0 |
% |
|
61 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
